Skip to content
healthcare.dev

ORPHENGESIC FORTE

NDC 61825-302, Orphenadrine Citrate, Aspirin and Caffeine, tablet, from Galt Pharmaceuticals, LLC.

Product NDC
61825-302
Status
Listed
Labeler
Galt Pharmaceuticals, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075141
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61825-302 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ORPHENADRINE CITRATE50 mg/1
  • ASPIRIN770 mg/1
  • CAFFEINE60 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Centrally-mediated Muscle Relaxation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Muscle Relaxant [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]

Package NDCNDC-11Package
61825-302-606182503026060 TABLET in 1 BOTTLE, PLASTIC (61825-302-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5bc485db-9d96-4291-aaa3-2a96ebf3098a

Use it

Look up 61825-302 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61825-302 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61825-302. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.